Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • April 2017
  • Supplement
  • HBS Case Collection

Imprimis (B)

By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
  • Format:Print
  • | Language:English
  • | Pages:5
ShareBar

Abstract

This case is a supplement to Imprimis (A). It describes the company’s decision to enter into the pharmaceutical compounding business in 2013–2014. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients’ eyes post cataract surgery, with the aim of replacing a complex regimen of prescription eye drops. After a successful launch of the compounded medication, Imprimis ran into complications when Medicare changed its policy regarding payment for the drug. Under the new policy, not only would Medicare not cover the medication, but patients could no longer pay for it out of pocket. Instead, the cost had to be absorbed by the physician or surgery center. Imprimis now had to figure out a way to deal with the effects of this policy, whether that be by lobbying for a policy change, creating a compounded eye drop treatment of their own, or moving out of the cataract treatment business entirely.

Keywords

Healthcare; Drug Compounding; Drug Development; Pharmaceuticals; Small Business; Decision-making, Business Model; Mark Baum; Imprimis; Decision Making; Strategy; Health Care and Treatment; Policy; Pharmaceutical Industry; United States

Citation

Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (B)." Harvard Business School Supplement 717-496, April 2017.
  • Purchase

About The Author

Ramon Casadesus-Masanell

Strategy
→More Publications

More from the Authors

    • June 2022
    • Faculty Research

    Bosch (B): Entering the Electric Bike Market

    By: Ramon Casadesus-Masanell, Oliver Gassmann, Felix Wortmann and Sven Jung
    • June 2022
    • Faculty Research

    Bosch (A): Entering the Electric Bike Market?

    By: Ramon Casadesus-Masanell, Oliver Gassmann, Felix Wortmann and Sven Jung
    • May 2022
    • Faculty Research

    Maestro Pizza (H): Making the Best of the Situation

    By: Ramon Casadesus-Masanell and Fares Khrais
More from the Authors
  • Bosch (B): Entering the Electric Bike Market By: Ramon Casadesus-Masanell, Oliver Gassmann, Felix Wortmann and Sven Jung
  • Bosch (A): Entering the Electric Bike Market? By: Ramon Casadesus-Masanell, Oliver Gassmann, Felix Wortmann and Sven Jung
  • Maestro Pizza (H): Making the Best of the Situation By: Ramon Casadesus-Masanell and Fares Khrais
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College